Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:731341 | 6480464 | epigallocatechin gallate results in increased expression of UTRN mRNA | CTD | PMID:22079256 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:731341 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of UTRN mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:731342 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of UTRN mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:731341 | 6480464 | EGF protein promotes the reaction [Estradiol results in decreased expression of UTRN mRNA] | CTD | PMID:24758408 | 17beta-estradiol | decreases expression | ISO | RGD:731341 | 6480464 | Estradiol results in decreased expression of UTRN mRNA | CTD | PMID:24758408 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731341 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UTRN mRNA | CTD | PMID:20106945, PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of UTRN mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UTRN mRNA | CTD | PMID:32109520, PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731342 | 6480464 | Tetrachlorodibenzodioxin affects the expression of UTRN mRNA | CTD | PMID:21570461, PMID:26377647 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of UTRN mRNA | CTD | PMID:28522335 | 4,4'-sulfonyldiphenol | increases methylation | ISO | RGD:731342 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased methylation of UTRN promoter | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RGD:731341 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased methylation of UTRN gene | CTD | PMID:31601247 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:731342 | 6480464 | Fenretinide results in decreased expression of UTRN mRNA | CTD | PMID:28973697 | aflatoxin B1 | decreases expression | ISO | RGD:731342 | 6480464 | Aflatoxin B1 results in decreased expression of UTRN mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | ISO | RGD:731341 | 6480464 | Aflatoxin B1 results in increased methylation of UTRN intron | CTD | PMID:30157460 | aflatoxin B1 | decreases expression | ISO | RGD:731341 | 6480464 | Aflatoxin B1 results in decreased expression of UTRN mRNA | CTD | PMID:22100608 | all-trans-retinoic acid | decreases expression | ISO | RGD:731341 | 6480464 | Tretinoin results in decreased expression of UTRN mRNA | CTD | PMID:23724009 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of UTRN mRNA | CTD | PMID:16483693 | apigenin | increases expression | ISO | RGD:731341 | 6480464 | Apigenin results in increased expression of UTRN mRNA | CTD | PMID:22028826 | aristolochic acid A | decreases expression | ISO | RGD:731341 | 6480464 | aristolochic acid I results in decreased expression of UTRN mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases mutagenesis | ISO | RGD:731341 | 6480464 | Benzo(a)pyrene results in increased mutagenesis of UTRN gene | CTD | PMID:25435355 | benzo[a]pyrene | multiple interactions | ISO | RGD:731342 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UTRN mRNA | CTD | PMID:27858113 | benzo[a]pyrene | decreases expression | ISO | RGD:731341 | 6480464 | Benzo(a)pyrene results in decreased expression of UTRN mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | decreases expression | ISO | RGD:731342 | 6480464 | Benzo(a)pyrene results in decreased expression of UTRN mRNA | CTD | PMID:19770486, PMID:21715664 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:731341 | 6480464 | 7 more ... | CTD | PMID:19150397, PMID:20382639 | benzo[b]fluoranthene | decreases expression | ISO | RGD:731342 | 6480464 | benzo(b)fluoranthene results in decreased expression of UTRN mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | RGD:731342 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UTRN mRNA | CTD | PMID:27858113 | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UTRN mRNA | CTD | PMID:18164116 | bisphenol A | increases expression | ISO | RGD:731342 | 6480464 | bisphenol A results in increased expression of UTRN mRNA | CTD | PMID:26063408 | bisphenol A | decreases methylation | ISO | RGD:731341 | 6480464 | bisphenol A results in decreased methylation of UTRN gene | CTD | PMID:31601247 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of UTRN gene | CTD | PMID:28505145 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of UTRN mRNA | CTD | PMID:30816183, PMID:34947998 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of UTRN mRNA | CTD | PMID:25181051 | butanal | decreases expression | ISO | RGD:731341 | 6480464 | butyraldehyde results in decreased expression of UTRN mRNA | CTD | PMID:26079696 | cadmium atom | decreases expression | ISO | RGD:731341 | 6480464 | Cadmium results in decreased expression of UTRN mRNA | CTD | PMID:23369406 | caffeine | affects phosphorylation | ISO | RGD:731341 | 6480464 | Caffeine affects the phosphorylation of UTRN protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | RGD:731342 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chromium(6+) | affects expression | ISO | RGD:731342 | 6480464 | chromium hexavalent ion affects the expression of UTRN mRNA | CTD | PMID:28472532 | chromium(6+) | decreases expression | ISO | RGD:731341 | 6480464 | chromium hexavalent ion results in decreased expression of UTRN mRNA | CTD | PMID:30690063 | chrysene | multiple interactions | ISO | RGD:731342 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UTRN mRNA | CTD | PMID:27858113 | chrysin | increases expression | ISO | RGD:731341 | 6480464 | chrysin results in increased expression of UTRN mRNA | CTD | PMID:22028826 | cisplatin | decreases expression | ISO | RGD:731341 | 6480464 | Cisplatin results in decreased expression of UTRN mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | RGD:731341 | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of UTRN mRNA | CTD | PMID:27392435 | clobetasol | decreases expression | ISO | RGD:731342 | 6480464 | Clobetasol results in decreased expression of UTRN mRNA | CTD | PMID:27462272 | clofibrate | increases expression | ISO | RGD:731342 | 6480464 | Clofibrate results in increased expression of UTRN mRNA | CTD | PMID:17585979 | clorgyline | increases expression | ISO | RGD:731341 | 6480464 | Clorgyline results in increased expression of UTRN mRNA | CTD | PMID:22028826 | clothianidin | decreases expression | ISO | RGD:731341 | 6480464 | clothianidin results in decreased expression of UTRN mRNA | CTD | PMID:31626844 | CU-O LINKAGE | decreases expression | ISO | RGD:731341 | 6480464 | cupric oxide results in decreased expression of UTRN mRNA | CTD | PMID:22077320 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of UTRN mRNA | CTD | PMID:26577399 | cyclosporin A | increases expression | ISO | RGD:731341 | 6480464 | Cyclosporine results in increased expression of UTRN mRNA | CTD | PMID:20106945 | cyclosporin A | decreases expression | ISO | RGD:731341 | 6480464 | Cyclosporine results in decreased expression of UTRN mRNA | CTD | PMID:25562108 | dibenz[a,h]anthracene | decreases expression | ISO | RGD:731342 | 6480464 | 1 more ... | CTD | PMID:26377693 | dicrotophos | increases expression | ISO | RGD:731341 | 6480464 | dicrotophos results in increased expression of UTRN mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | RGD:731341 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | equilin | increases expression | ISO | RGD:731341 | 6480464 | Equilin results in increased expression of UTRN mRNA | CTD | PMID:22028826 | ethanol | increases expression | ISO | RGD:731342 | 6480464 | Ethanol results in increased expression of UTRN mRNA | CTD | PMID:30319688 | ethanol | affects splicing | ISO | RGD:731342 | 6480464 | Ethanol affects the splicing of UTRN mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | RGD:731341 | 6480464 | Ethyl Methanesulfonate results in increased expression of UTRN mRNA | CTD | PMID:23649840 | fenamidone | increases expression | ISO | RGD:731342 | 6480464 | fenamidone results in increased expression of UTRN mRNA | CTD | PMID:27029645 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of UTRN mRNA | CTD | PMID:30307764 | folic acid | decreases expression | ISO | RGD:731342 | 6480464 | Folic Acid results in decreased expression of UTRN mRNA | CTD | PMID:25629700 | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of UTRN mRNA | CTD | PMID:25539665 | gallic acid | increases expression | ISO | RGD:731341 | 6480464 | Gallic Acid results in increased expression of UTRN mRNA | CTD | PMID:34408198 | glyphosate | increases methylation | EXP | | 6480464 | glyphosate results in increased methylation of UTRN gene | CTD | PMID:31011160 | hesperetin | increases expression | ISO | RGD:731341 | 6480464 | hesperetin results in increased expression of UTRN mRNA | CTD | PMID:22028826 | ivermectin | decreases expression | ISO | RGD:731341 | 6480464 | Ivermectin results in decreased expression of UTRN protein | CTD | PMID:32959892 | kaempferol | increases expression | ISO | RGD:731341 | 6480464 | kaempferol results in increased expression of UTRN mRNA | CTD | PMID:22028826 | leflunomide | increases expression | ISO | RGD:731341 | 6480464 | leflunomide results in increased expression of UTRN mRNA | CTD | PMID:22028826 | methamphetamine | increases expression | ISO | RGD:731342 | 6480464 | Methamphetamine results in increased expression of UTRN mRNA | CTD | PMID:26307267 | methyl methanesulfonate | increases expression | ISO | RGD:731341 | 6480464 | Methyl Methanesulfonate results in increased expression of UTRN mRNA | CTD | PMID:23649840 | methylseleninic acid | decreases expression | ISO | RGD:731341 | 6480464 | methylselenic acid results in decreased expression of UTRN mRNA | CTD | PMID:18548127 | mitoxantrone | affects response to substance | ISO | RGD:731341 | 6480464 | UTRN protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:731342 | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UTRN mRNA] | CTD | PMID:17942915 | N-nitrosodiethylamine | increases expression | ISO | RGD:731342 | 6480464 | Diethylnitrosamine results in increased expression of UTRN mRNA | CTD | PMID:17942915 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UTRN mRNA | CTD | PMID:18164116 | nabumetone | increases expression | ISO | RGD:731341 | 6480464 | nabumetone results in increased expression of UTRN mRNA, nabumetone results in increased expression of UTRN protein | CTD | PMID:22028826 | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of UTRN protein | CTD | PMID:33146391 | paracetamol | affects expression | ISO | RGD:731342 | 6480464 | Acetaminophen affects the expression of UTRN mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | RGD:731341 | 6480464 | Acetaminophen results in decreased expression of UTRN mRNA | CTD | PMID:21420995 | pentanal | decreases expression | ISO | RGD:731341 | 6480464 | pentanal results in decreased expression of UTRN mRNA | CTD | PMID:26079696 | phenazopyridine | increases expression | ISO | RGD:731341 | 6480464 | Phenazopyridine results in increased expression of UTRN mRNA | CTD | PMID:22028826 | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of UTRN mRNA | CTD | PMID:19162173 | phenylmercury acetate | increases expression | ISO | RGD:731341 | 6480464 | Phenylmercuric Acetate results in increased expression of UTRN mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:731341 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UTRN mRNA | CTD | PMID:27188386 | piperine | increases expression | ISO | RGD:731341 | 6480464 | piperine results in increased expression of UTRN mRNA | CTD | PMID:22028826 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of UTRN mRNA | CTD | PMID:19162173 | potassium chromate | multiple interactions | ISO | RGD:731341 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of UTRN mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:731341 | 6480464 | potassium chromate(VI) results in decreased expression of UTRN mRNA | CTD | PMID:22079256, PMID:22714537 | quinolin-8-ol | increases expression | ISO | RGD:731341 | 6480464 | Oxyquinoline results in increased expression of UTRN mRNA | CTD | PMID:21632981 | resveratrol | increases expression | ISO | RGD:731341 | 6480464 | resveratrol results in increased expression of UTRN mRNA | CTD | PMID:22028826 | resveratrol | increases expression | ISO | RGD:731342 | 6480464 | resveratrol results in increased expression of UTRN mRNA | CTD | PMID:22795790 | Riluzole | increases expression | ISO | RGD:731341 | 6480464 | Riluzole results in increased expression of UTRN mRNA | CTD | PMID:22028826 | SB 431542 | multiple interactions | ISO | RGD:731341 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of UTRN mRNA | CTD | PMID:22110744 | succimer | multiple interactions | ISO | RGD:731341 | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UTRN mRNA | CTD | PMID:26378955 | tetraphene | decreases expression | ISO | RGD:731342 | 6480464 | benz(a)anthracene results in decreased expression of UTRN mRNA | CTD | PMID:26377693 | tetraphene | multiple interactions | ISO | RGD:731342 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UTRN mRNA | CTD | PMID:27858113 | thiabendazole | increases expression | ISO | RGD:731341 | 6480464 | Thiabendazole results in increased expression of UTRN mRNA | CTD | PMID:22028826 | titanium dioxide | decreases expression | ISO | RGD:731342 | 6480464 | titanium dioxide results in decreased expression of UTRN mRNA | CTD | PMID:23557971 | trichostatin A | increases expression | ISO | RGD:731341 | 6480464 | trichostatin A results in increased expression of UTRN mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:731341 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UTRN mRNA | CTD | PMID:27188386 | triptonide | increases expression | ISO | RGD:731342 | 6480464 | triptonide results in increased expression of UTRN mRNA | CTD | PMID:33045310 | troglitazone | decreases expression | ISO | RGD:731342 | 6480464 | troglitazone results in decreased expression of UTRN mRNA | CTD | PMID:28973697 | trovafloxacin | decreases expression | ISO | RGD:731342 | 6480464 | trovafloxacin results in decreased expression of UTRN mRNA | CTD | PMID:35537566 | valproic acid | affects expression | ISO | RGD:731341 | 6480464 | Valproic Acid affects the expression of UTRN mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | RGD:731341 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UTRN mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | RGD:731341 | 6480464 | Valproic Acid results in increased expression of UTRN mRNA | CTD | PMID:23179753 more ... | vorinostat | increases expression | ISO | RGD:731341 | 6480464 | vorinostat results in increased expression of UTRN mRNA | CTD | PMID:27188386 | zinc dichloride | affects binding | ISO | RGD:731341 | 6480464 | zinc chloride binds to UTRN protein | CTD | PMID:17009962 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| Save what matters to you |
| {{ loginError }} |
| Sign in with your RGD account |
| Create New Account | Recover Password |
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
